Exondys 51 Drug Insight 2019

A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report

Press Release

“Exondys 51 Drug Insight 2019” report by DelveInsight provides comprehensive information of the drug, Exondys 51. It includes Exondys 51`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Exondys 51`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted sales of Exondys 51 till 2021. The report also throws light on Exondys 51`s market competition and emerging therapies in the same space as Exondys 51. A SWOT analysis of Exondys 51 is also featured. * Depending on information availability

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
• Patent information around Exondys 51 in United States (US) and Europe (EU) has been highlighted
• API manufacturers for Exondys 51 in United States, Europe, China and India
• The report contains historical and forecasted sales for Exondys 51 till 2021
• Comprehensive coverage of the emerging therapies (Phase III) in the space where Exondys 51 operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
• The report also features the SWOT analysis of Exondys 51

Reasons to Buy
• Establish a comprehensive understanding of the drug, Exondys 51
• Access to Exondys 51`s API manufacturers details to devise API procurement strategy for generic development
• Plan developmental timelines around Exondys 51`s patents for the major markets- US and EU
• Understand Exondys 51`s current and future growth through its historical and forecasted sales
• Identify and understand the current in-market competitors for Exondys 51
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify and plan ahead for prospective emerging players and their products operating in the same space as Exondys 51
• Identify opportunities in the same area as Exondys 51 with DelveInsight`s SWOT analysis

Request for sample pages

Table of contents

1. Report Introduction
2. Exondys 51 – Overview
• Product Description
• Route of Synthesis
• Mechanism of Action
• Pharmacology
• Pharmacodynamics
• Pharmacokinetics
• Adverse Reactions
• Clinical Trials
• Regulatory Milestones
• Product Development Activities
3. Global API Manufacturers
• United States
• Europe
• China
• India
4. Product Details
• United States
• Europe
5. Exondys 51 Global Sales Assessment
• Historical Global Sales
• Forecasted Global Sales
6. Patent Details
7. Market Competition
8. Emerging Therapies
8.1. Drug name: Company name
• Product Description
• Research & Development
• Product Development Activities
Other product profiles in the detailed reportÂ…..
9. SWOT Analysis
Consulting Services
About DelveInsight
Contact Us


Related Articles